心脏移植术后急性排斥反应的无创监测  

Non-invasive monitoring of acute rejection after heart transplantation

作　　者：张振[1] 王武军[1] 

机构地区：[1]第一军医大学附属南方医院胸心血管外科，广东广州510515

出　　处：《医学研究生学报》2003年第11期872-874,共3页Journal of Medical Postgraduates

摘　　要：心脏移植已成为治疗终末期心脏病的有效方法 ,目前影响其远期生存率的主要因素是移植后的急性和慢性排斥反应。经颈内静脉心内膜活检 ,已成为诊断心脏移植术后排斥反应的“金标准” ,但还存在一定局限性。心电图、超声心动图、免疫学及影像学等无创手段 ,能有效地监测心脏移植术后排斥反应的发生和指导心内膜活检的进行。Heart transplantation(HT) has been an effective method to treat end-stage heart disease, one main factor affecting the long-term survival rate is acute and/or chronic rejection after HT. Trans internal jugular endomyocardial biopsy(EMB) has been the 'gold standard' to judge the rejection after HT, but it is also limited. Electrocardiogram ,echocardiogram, immunological monitoring and imaging monitoring can judge the rejection after HT and induce the EMB.

关 键 词：心脏移植 急性排斥反应 无创监测 

分 类 号：R654.2[医药卫生—外科学]